What was Matthew Paul Larson’s share position after the Slide Insurance (SLDE) sale?

After selling 11,250 Slide Insurance common shares acquired from the option exercise, Matthew Paul Larson’s directly owned common stock from this transaction was reduced to zero. The Form 4 shows 0 shares of common stock directly owned following the reported sale entry.

Slide Insurance (SLDE) CRO exercises options, sells 11,250 shares at $18

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. Chief Risk Officer Matthew Paul Larson exercised options and sold shares in a planned transaction. On April 6, he exercised stock options to acquire 11,250 shares of common stock at $0.79 per share, then sold 11,250 shares at $18.00 per share in an open-market transaction.

The filing notes these fully vested options were exercised and sold pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025, indicating the trades were pre-scheduled rather than discretionary.

Insider Trade Summary 10b5-1

Net Seller: 11,250 shares ($202,500)

Net Sell 3 txns

Insider LARSON MATTHEW PAUL

Role Chief Risk Officer

Sold 11,250 shs ($203K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	11,250	$0.00	--
Exercise	Common Stock	11,250	$0.79	$9K
Sale	Common Stock	11,250	$18.00	$203K

Holdings After Transaction: Stock Option (Right to Buy) — 31,250 shares (Direct); Common Stock — 11,250 shares (Direct)

Footnotes (1)

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025. These stock options are fully vested and exercisable.

Key Figures

Options exercised: 11,250 shares Exercise price: $0.79 per share Shares sold: 11,250 shares +3 more

6 metrics

Options exercised 11,250 shares Stock options exercised on April 6, 2026

Exercise price $0.79 per share Stock Option (Right to Buy) conversion price

Shares sold 11,250 shares Common stock sold on April 6, 2026

Sale price $18.00 per share Open-market common stock sale

Options expiration February 21, 2032 Original expiration date of exercised options

Common shares after sale 0 shares Directly owned common stock following reported sale

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy, open-market sale, fully vested and exercisable

4 terms

Rule 10b5-1 trading plan financial

"Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy financial

"security_title: Stock Option (Right to Buy)"

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

fully vested and exercisable financial

"These stock options are fully vested and exercisable."

Form 4 Insider Transactions: What Each Field Means →

04/08/2026 - 08:46 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LARSON MATTHEW PAUL

(Last)

(First)

(Middle)

4221 W BOY SCOUT BLVD

SUITE 200

(Street)

TAMPA

FLORIDA

33607

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Risk Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/06/2026		M		11,250	A	$0.79	11,250	D
Common Stock	04/06/2026		S		11,250⁽¹⁾	D	$18	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$0.79	04/06/2026		M⁽¹⁾			11,250	⁽²⁾	02/21/2032	Common Stock	11,250	$0	31,250	D

Explanation of Responses:

1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.

2. These stock options are fully vested and exercisable.

	/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Slide Insurance (SLDE) report for Matthew Paul Larson?

Slide Insurance reported that Chief Risk Officer Matthew Paul Larson exercised stock options for 11,250 shares, then sold 11,250 common shares at $18.00 each. The options had a $0.79 exercise price and were fully vested and exercisable before the transaction.

Was the Slide Insurance (SLDE) insider trade made under a Rule 10b5-1 plan?

Yes. The Form 4 states the options were exercised and the shares sold pursuant to a Rule 10b5-1 trading plan adopted by Matthew Paul Larson on December 4, 2025. Such pre-arranged plans typically indicate routine, pre-scheduled portfolio transactions.

How many Slide Insurance (SLDE) shares did the insider sell and at what price?

Matthew Paul Larson sold 11,250 shares of Slide Insurance common stock at $18.00 per share. These shares came from exercising stock options at $0.79 per share on the same date, effectively converting an option position into cash through an exercise-and-sell pattern.

What type of derivative security did the Slide Insurance (SLDE) insider exercise?

He exercised a Stock Option (Right to Buy) covering 11,250 underlying shares of Slide Insurance common stock at an exercise price of $0.79. The filing notes these stock options were fully vested and exercisable before the transaction and originally expired on February 21, 2032.